MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Diabetes & Endocrinology

HealthDay 06 September at 04.00 PM

Noise, Air Pollution May Impact Fertility

Air pollution is associated with a higher risk for an infertility diagnosis in men, while road traffic noise pollution is associated with a higher risk for an infertility diagnosis in women aged 35 years and older, according to a study published online Sept. 4 in The BMJ.Mette Sørensen, Ph.D., from the Danish Cancer Institute in Co

MedScape 06 September at 07.24 AM

A New Focus for Cushing Syndrome Screening in Obesity

Screening for Cushing syndrome in patients with obesity revealed a low prevalence, with nearly all the risk for the rare endocrine disorder in the metabolically unhealthy obesity phenotype.

MedScape 06 September at 04.39 AM

Health Rounds: Next Generation Lilly Weight-loss Drug Shows Added Heart, Liver Benefits

Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to show promising clinical trial results for...

MedScape 06 September at 03.37 AM

How 'Oatzempic' Stacks up to Ozempic

In people with diabetes, the "oatzempic" online diet fad may lead to increased glucose, decreased muscle mass, and malnutrition.

HealthDay 05 September at 10.28 PM

Interactive Map Highlights PAD Amputation Hotspots in the U.S.

A new interactive map has been created by the American Heart Association (AHA) to illustrate the risk for leg, foot, or toe amputations due to peripheral artery disease (PAD) in different regions of the United States.Mississippi has the highest risk for lower limb amputation, followed by Texas, Louisiana, Alabama, and South Carolina, the <a hr

HealthDay 05 September at 03.06 PM

Report Reveals Extent of Cost-Related Medication Nonadherence in Seniors

About 3.5 percent of older adults do not take prescription medications due to cost and a similar percentage do not take medications as prescribed due to cost, according to a study published online Sept. 5 in the&nbsp;National Health Statistics Reports, a publication from the National Center for Health Statistics.Robin A. Cohen, Ph.D.,

MedScape 05 September at 05.06 AM

How Fake Ozempic Batch Numbers Help Criminal Groups Spread Dangerous Drugs

In December, Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles (400 km) to Mexico to buy cheap Ozempic to help him lose weight. Going home, he...

MedScape 05 September at 05.02 AM

Factbox-How to Find and Check an Ozempic Batch Number

Explosive demand and high prices for Novo Nordisk and Eli Lilly's weight loss and diabetes drugs have fueled a criminal effort to package autoinjector pens containing other...

HealthDay 04 September at 02.52 PM

High Insulin Levels Genetically Linked to Lower Lipoprotein(a)

There is an association between genetically predicted increased insulin concentrations and decreased concentrations of circulating lipoprotein(a) (Lp[a]), according to a study published online Aug. 29 in&nbsp;Cardiovascular Diabetology&nbsp;to coincide with the European Society of Cardiology Congress 2024, held from Aug. 30 to Sept. 2 in Lo

MedScape 04 September at 03.22 AM

Ozempic Shortages in EU Will Not Affect All Member States - Novo Nordisk

Intermittent shortages of diabetes drug Ozempic in the European Union that are expected to continue into the final quarter of 2024 because of strong demand will not affect...

HealthDay 03 September at 08.11 PM

Semaglutide Does Not Increase Psychiatric Complications in Overweight, Obesity

Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior among adults with overweight or obesity, according to a study published online Sept. 3 in JAMA Internal Medicine.Thomas A. Wadden, Ph.D., from the Perelman School of Medicine at the University of Pennsylvania in Phi

HealthDay 03 September at 08.11 PM

SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug. 28 in&nbsp;The BMJ.Anna Shin, from Seoul National University Bundang Hospital in South Korea, and colleagues compared the risk for dementia associated with SGLT-2 inhibitors versus dipe

HealthDay 03 September at 04.09 PM

Interleukin-6 May Boost Prediction of Obesity-Related Cancers

In patients with newly diagnosed type 2 diabetes, baseline interleukin-6 (IL-6) levels may enhance prediction of new-onset obesity-related cancers, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.Mathilde Dahlin Bennetsen, from th

MedScape 03 September at 04.41 AM

Eat a Plant-Based Diet to Lower Diabetes Risk

A new paper based on self-reported diet information from major studies and analysis of biomarkers added to the evidence about risks for meat consumption.

MedScape 30 August at 09.54 AM

Drugs, Complications, and Collaborations All on EASD Agenda

The upcoming EASD meeting will feature new data on once-weekly insulin and GLP-1 drugs and joint society collaborations addressing diabetes complications.

MedScape 30 August at 05.43 AM

Intermittent Fasting Aids Patients With Prediabetes or T2D

The approach is associated with reductions in body weight, BMI, and A1c levels.

MedScape 30 August at 03.42 AM

How Do Plant-based Foods Reduce Type 2 Diabetes Risk?

A higher intake of lignans, found in seeds, whole grains, and coffee and tea, was associated with a decreased risk of developing type 2 diabetes.

MedScape 29 August at 04.25 AM

Men, Women, & Exercise: Metabolism Differs at Starting Line

The muscles of sedentary men and women with overweight and obesity differ in burning sugar and fatty acids at the start of an exercise program but draw even after training, multi-omics data show.

HealthDay 28 August at 09.56 PM

Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders

There is a consistent, bidirectional association between chronic diabetes complications (CDCs) and mental health disorders (MHDs), according to a study published online July 15 in&nbsp;Diabetes Care.Maya Watanabe, from the University of Michigan in Ann Arbor, and colleagues examined bidirectional associations between the timing of CD

MedScape 28 August at 01.22 PM

NICE: Give People With Adrenal Insufficiency Emergency Kits

People with adrenal insufficiency should be given emergency kits to help avoid hospital admission, said NICE in its new clinical guideline.

MedScape 28 August at 09.00 AM

Continuous Glucose Monitor Benefits All Ages With Diabetes

Intermittently scanned continuous glucose monitoring improved glycaemic outcomes in those older and younger than 65 years, but the older group may need individualised targets.

HealthDay 27 August at 09.50 PM

Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time

Physicians who adopt team-based documentation, defined as use of coauthored documentation with another clinical team member, experience increased visit volume and reduced documentation time, according to a study published online Aug. 26 in JAMA Internal Medicine.Nate C. Apathy, Ph.D., from the University of Maryland School of Public He

HealthDay 27 August at 09.47 PM

FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type 2 Diabetes

On Monday, the U.S. Food and Drug Administration approved the Insulet Omnipod 5 insulin delivery system for patients with type 2 diabetes. It is the first such system for use by people with the more prevalent form of the disease.The FDA first signed off on the system, which automatically adjusts insulin delivery as needed, for type 1 diabetes i

HealthDay 27 August at 04.09 PM

Meat Consumption Linked to Increased Incidence of Type 2 Diabetes

Consumption of unprocessed red meat, processed meat, and poultry is associated with an increased incidence of type 2 diabetes, according to a study published online in the September issue of The Lancet Diabetes &amp; Endocrinology.Chunxiao Li, Ph.D., from the University of Cambridge School of Clinical Medicine in the United Kingdom, an

HealthDay 27 August at 02.12 PM

Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price

Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers.The new 2.5 milligram (mg) and 5 mg weekly dose vials differ from the standard preloaded injector pens that are used to administer Zepbound (tirzepatide) and co

MedScape 27 August at 09.41 AM

Semaglutide Coverage Could Raise Medicare Costs by Billions

Medicare's expanded coverage for semaglutide meant that around one in seven Medicare beneficiaries with a high BMI would be newly eligible for semaglutide treatment.

MedScape 27 August at 06.59 AM

Thyroid Surgery Increases Kidney Disease Risk

Patients who underwent total thyroidectomy had an increased risk for chronic kidney disease, particularly those who developed hypoparathyroidism.

MedScape 27 August at 06.49 AM

Lilly Launches Smallest Single-dose Vials Of Zepbound for $399

Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its...

MedScape 27 August at 06.49 AM

Lilly Launches Vials Of Weight-loss Drug Zepbound for as Low as $399 a Month

Eli Lilly said on Tuesday it has begun selling vials of the lowest starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month's supply...

HealthDay 26 August at 09.45 PM

Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM

For older adults with type 2 diabetes, the risk for dementia seems similar with sodium-glucose cotransporter 2 (SGLT2) inhibitors and the glucagon-like peptide 1 receptor agonist (GLP-1 RA) dulaglutide, according to a study published online Aug. 27 in the Annals of Internal Medicine.Bin Hong, from the School of Pharmacy at Sungkyunkwan

MedScape 26 August at 05.19 PM

FDA Clears the Omnipod 5 System for Type 2 Diabetes

New indication represents the first for use of an automated insulin delivery system in people with type 2 diabetes who require insulin treatment.

MedScape 26 August at 09.00 AM

First Over-the-Counter Continuous Glucose Monitor Launches

Dexcom's Stelo, designed for people older than 18 years with diabetes or prediabetes not on insulin or not at a risk for hypoglycemia, will be available without a prescription.

MedScape 26 August at 08.44 AM

Lobectomy Doesn't Raise Reoperation Rates in Thyroid Cancer

Despite a shift toward performing more initial lobectomies for thyroid cancer following the release of the 2015 ATA guidelines, the rate of late reoperations remained unchanged.

HealthDay 23 August at 10.39 PM

Type 2 Diabetes Prevalence Rose in the United States From 2012 to 2022

The prevalence of diabetes increased in the United States from 2012 to 2022, according to a research letter published online July 18 in&nbsp;Diabetes, Obesity and Metabolism.Sulakshan Neupane, from the University of Georgia in Athens, and colleagues examined recent national trends and disparities in self-reported diabetes prevalence amo

HealthDay 23 August at 10.37 PM

Exposure to Tobacco on TV, Streaming Varies by Sociodemographics

Exposure to tobacco on television or streaming platforms differs by key sociodemographic and behavioral characteristics, according to a study published online Aug. 22 in&nbsp;JAMA Network Open.Henry K. Onyeaka, M.D., from Harvard Medical School in Boston, and colleagues examined the prevalence and factors associated with exposure to tob

HealthDay 23 August at 03.54 PM

Inflammation in Childhood Linked to Onset of Mental Health Disorders

Low-grade systemic inflammation across childhood and adolescence is associated with the subsequent onset of mental health disorders, according to a study published online Aug. 21 in JAMA Psychiatry.Edward R. Palmer, M.B.B.S., from the University of Birmingham in the United Kingdom, and colleagues examined trajectories of inflammation, a

MedScape 23 August at 06.18 AM

Steps to Take for Diagnosing Cushing Syndrome

Your patient's "round face" might be the first clue that he or she has Cushing syndrome, but there are other symptoms as well. How can you accurately diagnose the condition?

MedScape 23 August at 02.58 AM

PCOS Linked to Higher Risk for Cardiometabolic Diseases

Women with polycystic ovary syndrome showed an increased risk for cardiometabolic diseases, with the risk varying according to phenotype.

HealthDay 22 August at 10.05 PM

Study Reveals Heart Failure Risks in American Indian Communities

A study published online Aug. 21 in the Journal of the American Heart Association reveals the major contributors to heart failure risk in American Indians, highlighting the roles of age, smoking, and diabetes.Irene Martinez-Morata, M.D., M.P.H., from the Columbia University Mailman School of Public Health in New York City, and colleag

HealthDay 22 August at 09.33 AM

Americans Have Mixed Feelings About AI in Health Care, Poll Finds

Most Americans believe artificial intelligence should be used to improve health care, a new national survey reports.However, many are still a little queasy over some of the implications of widespread AI use, the <a href="https://wexnermedical.osu

MedScape 22 August at 01.29 AM

SGLT2 vs DPP4 Inhibitor: Which Protects Liver Better in T2D?

SGLT2 inhibitors did not reduce the risk for adverse liver outcomes more than DPP-4 inhibitors in patients with type 2 diabetes and metabolic dysfunction–associated steatotic liver disease.

HealthDay 21 August at 03.42 PM

Study Looks at Impact of Hypothyroidism, Hypothyroxinemia in Pregnancy

For women with subclinical hypothyroidism (SH) or hypothyroxinemia (HT) diagnosed during the first half of pregnancy, SH is associated with higher rates of overt hypothyroidism or thyroid replacement therapy within five years of delivery, according to a study published online July 31 in Thyroid.Michael W. Varner, M.D., from the Unive

HealthDay 21 August at 03.31 PM

2020 to 2021 Saw Decline in Life Expectancy for 39 States, Increase for 11

From 2020 to 2021, life expectancy at birth declined for 39 U.S. states and increased for 11 states, according to the Aug. 21 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Elizabeth Arias, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues p

HealthDay 21 August at 03.20 PM

Semaglutide-Linked Suicidal Ideation ID'd in Disproportionality Analysis

Semaglutide-associated suicidal ideation has been identified in a disproportionality analysis, according to a study published online Aug. 20 in JAMA Network Open.Georgios Schoretsanitis, M.D., Ph.D., from Northwell Health in Glen Oaks, New York, and colleagues examined potential signals for suicidal and self-injurious adverse drug re

MedScape 21 August at 07.33 AM

Will Compounding 'Best Practices' Guide Reassure Clinicians?

The new guide aimed to educate compounding pharmacists and reassure prescribers about the ethical, legal, and practical considerations that must be addressed to ensure quality standards.

MedScape 21 August at 05.07 AM

Tirzepatide Reduces Progression From Prediabetes to T2D

Topline data from Lilly's SURMOUNT 1 trial shows a 94% reduction in the development of type 2 diabetes among those with prediabetes and overweight/obesity.

HealthDay 20 August at 03.50 PM

More Than Half of Older Adults Very Concerned About Medical Costs

Ahead of the 2024 election, more than half of older U.S. adults report being very concerned about the costs of medical care, according to a research letter published online Aug. 14 in the&nbsp;Journal of the American Medical Association.John Z. Ayanian, M.D., from the University of Michigan in Ann Arbor, and colleagues surveyed a natio

MedScape 20 August at 09.06 AM

Gender and Sports: Can Science Enable Fair Competition?

The allegations against Algerian boxer Imane Khelif raised the complicated question of intersexuality and its implications for competitive sports.

MedScape 20 August at 08.39 AM

Repurposed CT Scan Data Can Reveal Hidden Diabetes Risks

Automated analysis of past CT scans predicted current and future risks for type 2 diabetes better than traditional measures, found a large retrospective study.

MedScape 20 August at 04.55 AM

More Clinical Benefits With Tirzepatide vs GLP-1 RA in T2D

A large retrospective study of electronic medical records found better cardiovascular and renal outcomes in patients with type 2 diabetes treated with tirzepatide vs GLP-1 RAs.

HealthDay 19 August at 10.00 PM

Low Nurse Staffing Tied to Higher Risk for Patient Death

The risk for patient death associated with low nurse staffing is only partly alleviated by using temporary staff to fill shortfalls, according to a study published online Aug. 19 in&nbsp;JAMA Network Open.Peter Griffiths, R.N., Ph.D., from the University of Southampton in the United Kingdom, and colleagues explored the association betwe

HealthDay 19 August at 03.30 PM

Heme Iron Intake Linked to Increased Risk for Type 2 Diabetes

Heme iron intake is associated with an increased risk for type 2 diabetes (T2D), according to a study published online Aug. 13 in Nature Medicine.Fenglei Wang, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues analyzed data from 204,615 participants in large U.S. cohorts during up to 36 years to examine

HealthDay 16 August at 09.24 PM

Automated Multiorgan CT Can Predict Diabetes, Other Conditions

Automated multiorgan computed tomography (CT), including visceral fat, can predict diabetes and associated cardiometabolic conditions, according to a study published online Aug. 6 in Radiology.Yoosoo Chang, M.D., Ph.D., from Sungkyunkwan University School of Medicine in Seoul, South Korea, and colleagues examined the ability of automate

HealthDay 16 August at 02.36 PM

Risk for Developing Type 1 Diabetes Doubled With Paternal Link

Individuals are less likely to have type 1 diabetes if their mother has the condition than if their father is affected, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.Lowri A. Allen, M.B.Ch.B., from Cardiff University in the Unite

MedScape 16 August at 07.55 AM

New Data Shed Light on Type 1 Diabetes Male Predominance

Gender prevalence is equal in young children, but trajectory appears to diverge around puberty.

MedScape 16 August at 07.03 AM

GLP-1 RAs Reduce Hyperkalemia Risk, Prolong RASi Use

Two classes of newer medications for glycemic control in type 2 diabetes differed in hyperkalemia risk and discontinuation of renin-angiotensin system inhibitors, a large cohort study found.

MedScape 16 August at 03.46 AM

Medtronic Revamps Its Continuous Glucose Monitor Platform

The company will launch two new sensors that are compatible with its insulin pump and smart insulin pen products and will also partner with Abbott Diabetes Care for a bespoke sensor.

MedScape 16 August at 01.42 AM

What Every Provider Needs to Know About Type 1 Diabetes

A freelance journalist shares tips based on her experience living with type 1 diabetes, including how it differs from type 2 in ways that may be underappreciated in nonspecialist settings.

HealthDay 15 August at 09.57 PM

FDA Starts Phase II of Efforts to Reduce Salt Levels in Food

The U.S. Food and Drug Administration on Thursday announced Phase II of its initial efforts to cut dietary salt intake by Americans.U.S. Dietary Guidelines recommend that a person consume no

HealthDay 15 August at 03.51 PM

Improving PTSD May Also Improve Diabetes Outcomes

No longer meeting diagnostic criteria for posttraumatic stress disorder (PTSD) is associated with a lower risk for poor diabetes outcomes, particularly among younger veterans, according to a study published online Aug. 13 in&nbsp;JAMA Network Open.Jeffrey F. Scherrer, Ph.D., from the Saint Louis University School of Medicine, and coll

HealthDay 15 August at 03.47 PM

Low-Cost, Group-Based Lifestyle Intervention Aids Diabetes Outcomes

Even individuals with a high genetic risk for type 2 diabetes (T2D) benefit from a low-cost, group-based intervention focused on healthy diet and physical activity, according to a study recently published online in the&nbsp;Journal of Clinical Endocrinology &amp; Metabolism.Maria Anneli Lankinen, Ph.D., from the University of Eastern

MedScape 15 August at 12.46 PM

T2D Fracture Risk Likely Due to Impaired Physical Function

Poorer physical function, not poorer bone mineral density (BMD), could be the principal reason for the increased fracture risk in older women with type 2 diabetes (T2D).

MedScape 15 August at 12.00 PM

T1D: Bone Health May Falter Before Nerves in Adolescence

The onset of diabetic neuropathy was not necessary for the deterioration of bones in adolescent girls with T1D.

HealthDay 15 August at 11.36 AM

New Deals Will Cut Medicare Costs for Expensive Drugs

The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs used by American seniors.Taxpayers should save $6 billion because of the new prices, while seniors using Medicare could save roughly $1.5 billion on their medications, the U.S. Centers for

MedScape 15 August at 06.53 AM

'New Era' in Insulin Possible if Research Successful

Six global research projects have been granted £15 million to develop novel insulin analogs that work better than current products.

MedScape 15 August at 05.00 AM

Monitor Antiobesity Drug Dosing After Rapid Weight Loss

In a 'teachable moment' case, a patient who did not have their levothyroxine dose adjusted after rapid weight loss with tirzepatide wound up in the emergency department.

HealthDay 14 August at 03.53 PM

Past-Month Cannabis Use Increasing Among Adults With Diabetes

Among U.S. adults with diabetes, cannabis use in the past month increased by 33.7 percent from 2021 to 2022, according to a research letter published online July 22 in Diabetes Care.Benjamin H. Han, M.D., M.P.H., from the University of California, San Diego, School of Medicine in La Jolla, and colleagues estimated the most recent nat

HealthDay 14 August at 03.45 PM

Clinicians Are Interested in Climate Change Education

Most clinicians show positive attitudes toward education in climate change, according to a study published online Aug. 8 in&nbsp;JAMA Network Open.Wynne Armand, M.D., from the Center for the Environment and Health at Massachusetts General Hospital in Boston, and colleagues evaluated whether a quality incentive program measure for cli

MedScape 14 August at 11.14 AM

Lilly Demands Doctors Stop Selling Copycat Weight-loss Drugs

Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days to stop the promotion of the compounded versions of its drugs for weight loss and...

MedScape 14 August at 10.52 AM

Can Dry Fasting Help With Metabolic Disorders, Diabetes?

Despite the social media hype and a few very small studies, dry fasting is unlikely to improve health and may cause harm.

MedScape 14 August at 08.05 AM

Intermittent Fasting Aids Weight Loss in Prediabetes and T2D

Intermittent fasting reduced body weight and BMI and improved glycemic outcomes in adults with prediabetes or T2D.

MedScape 14 August at 04.49 AM

Processed Foods Linked to Diabetic Complications

Consuming more ultraprocessed food was linked to an increased risk for microvascular complications, especially diabetic kidney disease, in a cohort of patients with T2D.

HealthDay 13 August at 03.41 PM

Poor Long-Term Sleep Trajectories Tied to Diabetes

Adults with suboptimal sleep duration trajectories are more likely to develop incident diabetes, according to a study published online June 27 in&nbsp;Diabetologia.Qian Xiao, Ph.D., M.P.H., from the University of Texas Health Science Center at Houston, and colleagues assessed long-term trajectories of sleep duration and incident diabet

HealthDay 13 August at 03.36 PM

PCOS Linked to Increased Odds of Eating Disorders

Polycystic ovary syndrome (PCOS) is associated with an increased likelihood of any eating disorder, according to a review published online Aug. 8 in the Journal of Clinical Endocrinology &amp; Metabolism.Laura G. Cooney, M.D., from the University of Wisconsin in Madison, and colleagues conducted a systematic review and meta-analysis to

HealthDay 12 August at 09.50 PM

GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with lower rates of hyperkalemia and a lower rate of renin-angiotensin system inhibitor (RASi) discontinuation compared with treatment with dipeptidyl peptidase-4 inhibitors (DPP-4is) among patients with type 2 diabetes (T2D), according to a study published online Aug. 1

HealthDay 12 August at 04.11 PM

Risks for Mortality, Adverse Heart, Kidney Events Lower With Tirzepatide for T2DM

For patients with type 2 diabetes, treatment with tirzepatide (a dual glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide receptor agonist) is associated with lower risks for all-cause mortality and adverse cardiovascular and kidney events compared with glucagon-like peptide 1 receptor agonist treatment (GLP-1 RA), according to a s

HealthDay 09 August at 08.15 PM

Neighborhood Socioeconomic Status Linked to Premature Mortality

Low neighborhood socioeconomic status (SES) is associated with premature mortality, according to a study published online Aug. 8 in JAMA Network Open.Wayne R. Lawrence, Dr.P.H., from the National Institutes of Health in Rockville, Maryland, and colleagues examined the association of life-course neighborhood SES and premature mortality in

HealthDay 09 August at 08.10 PM

1990 to 2018 Saw Global Rise in Sugar-Sweetened Beverage Consumption by Youth

Intake of sugar-sweetened beverages (SSBs) among children and adolescents increased by 23 percent globally from 1990 to 2018, according to a study published online Aug. 7 in&nbsp;The BMJ.Laura Lara-Castor, Ph.D., from the Friedman School of Nutrition Science and Policy at Tufts University in Boston, and colleagues quantified global intak

HealthDay 09 August at 03.57 PM

Remission of Type 2 Diabetes Feasible With Soup and Shake Diet Intervention

A behavioral intervention designed to support weight loss can yield remission of type 2 diabetes, according to a study published online Aug. 5 in The Lancet Diabetes &amp; Endocrinology.Jonathan Valabhji, M.D., from NHS England in the United Kingdom, and colleagues assessed remission of type 2 diabetes among participants in the NHS Type

HealthDay 09 August at 03.49 PM

Fracture Risk Higher in Women With T2DM Due to Poorer Physical Function

Women with type 2 diabetes (T2D) have higher bone mineral density (BMD) and better bone microarchitecture, but poorer physical function than women without diabetes, according to a study published online Aug. 7 in JAMA Network Open.Michail Zoulakis, M.D., from the Sahlgrenska Osteoporosis Centre at the University of Gothenburg in Sweden,

HealthDay 08 August at 11.00 PM

CDC Presents Provisional Mortality Data for 2023 in the United States

In 2023, there was a provisional total of 3,090,582 deaths in the United States, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Farid B. Ahmad, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues

HealthDay 08 August at 04.14 PM

HbA1c Stability Tied to Lower Risk for Alzheimer Disease and Related Dementias

Increased glycated hemoglobin (HbA1c) stability within patient-specific target ranges is associated with a lower risk for Alzheimer disease and related dementias (ADRD), according to a study published online Aug. 2 in&nbsp;JAMA Network Open.Patricia C. Underwood, Ph.D., from the William F. Connell School of Nursing at Boston College, a

HealthDay 08 August at 03.42 PM

ChatGPT Only Gets Diagnoses Correct Half of the Time

ChatGPT is not accurate as a diagnostic tool, but does offer some medical educational benefits, according to a study published online July 31 in&nbsp;PLOS ONE.Ali Hadi, from the Schulich School of Medicine and Dentistry at Western University in London, Ontario, Canada, and colleagues investigated ChatGPT’s diagnostic accuracy and utili

HealthDay 07 August at 03.13 PM

Short, Long Sleep Duration Tied to Microvascular Disease in Type 2 Diabetes

For individuals newly diagnosed with type 2 diabetes mellitus (T2DM), both short and long sleep duration are associated with microvascular disease, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.Mette S. Johansen, from Odense Un

HealthDay 07 August at 03.10 PM

Complex Interaction Seen Between Social Determinants of Health, Mortality

There is a complex interaction among social determinants of health with mortality risk, but a scoring system is able to identify subgroups with a high risk for mortality, according to a study published online Aug. 5 in BMJ Open.Marie-Pier Bergeron-Boucher, Ph.D., from the Interdisciplinary Centre on Population Dynamics at Syddansk Uni

HealthDay 07 August at 10.47 AM

EPA Bans Vegetable Pesticide That Can Harm Fetuses

In an historic move, the Environmental Protection Agency on Tuesday banned the use of a pesticide that can harm fetuses.Known as dimethyl tetrachloroterephthalate (DCPA or Dacthal), the weedkiller is used on a variety of crops, including broccoli, onions, kale, Brussels sprouts and cabbage.However, when a pregnant woman is exposed to th

HealthDay 06 August at 04.02 PM

Digital Diabetes Prevention Program Cost-Effective for Preventing T2D

For individuals with prediabetes, a digital diabetes prevention program (d-DPP) is cost-effective compared with an in-person lifestyle intervention for preventing development of type 2 diabetes (T2D), according to a study published online July 26 in Diabetes, Obesity and Metabolism.Sooyeol Park, from the Tulane University School of Publ

HealthDay 06 August at 03.50 PM

City-Level Taxes on Sugar-Sweetened Beverages Tied to Lower Youth BMI

City-level excise taxes on sugar-sweetened beverages (SSBs) are associated with lower body mass index (BMI) among youths, according to a study published online July 31 in&nbsp;JAMA Network Open.Deborah Rohm Young, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues examined whether city-level excise taxes on SS

HealthDay 06 August at 03.41 PM

Antibody-Positive Males Face Higher Risk for Type 1 Diabetes Progression

The risk for progression to type 1 diabetes (T1D) is significantly higher in antibody-positive males compared with females, with age differences in risk trajectories, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of Diabetes, being held from Sept. 9 to 13 in Madrid.Erin L. Templema

HealthDay 05 August at 04.03 PM

2021 to 2023 Saw Considerable Increase in Semaglutide Fills

From 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum.Christopher Scannell, M.D., Ph.D., from the University of Southern California in Los Angeles, and colleagues analyzed trends in prescriptions dispensed at retail pharmac

HealthDay 02 August at 10.57 PM

Long-Term Low-Carb Diet Efficacious for Treating Dyslipidemia in T2D

For individuals with type 2 diabetes, long-term low-carbohydrate diets (LCD) are efficacious for treatment of dyslipidemia but do not affect glycemic control, according to a review published online July 24 in the Journal of Diabetes Investigation.Takahiro Ichikawa, from the Kyoto Prefectural University of Medicine in Japan, and colleague

HealthDay 02 August at 04.03 PM

Semaglutide Products Being Sold Online Without Prescriptions

Semaglutide products are being sold online, with products likely unregistered or unlicensed, according to a research letter published online Aug. 2 in JAMA Network Open.Amir Reza Ashraf, Pharm.D., from the University of Pécs in Hungary, and colleagues conducted a risk assessment of semaglutide online sourcing. Websites advertising semagl

HealthDay 01 August at 04.11 PM

CDC Report Addresses Nonfinancial Access Barriers to Care in 2022

Nonfinancial access barriers to care represent a persistent problem in the United States, with more than 12 percent of adults reporting being too busy to go to a provider, according to a study published online Aug. 1 in the&nbsp;National Health Statistics Reports, a publication from the National Center for Health Statistics.Amanda E. N

HealthDay 31 July at 10.57 PM

58.7 Percent of U.S. Adults Walked for Leisure in Past Week in 2022

In 2022, 58.7 percent of adults walked for leisure in the past seven days and 16.2 percent of adults walked for transportation, according to a July data brief published by the National Center for Health Statistics.Dzifa Adjaye-Gbewonyo, Ph.D., and Elizabeth M. Briones, Ph.D., from the National Center for Health Statistics in Hyattsville, Mary

HealthDay 31 July at 04.04 PM

Common Genetic Risk Seen for Primary Ovarian Insufficiency, Cancer

There seems to be a common genetic risk for primary ovarian insufficiency (POI) and reproductive cancer risk, according to a study published online July 12 in the Journal of Clinical Endocrinology &amp; Metabolism.Kristina Allen-Brady, Ph.D., M.P.H., from the Huntsman Can

HealthDay 31 July at 03.53 PM

Cholesterol Absorption Inhibitors May Cut Risk for Liver Cancer

The use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in&nbsp;Cancer.Shahriar A. Zamani, Ph.D., from the National Cancer Institute at the National Institutes of Health in Rockville, Maryland, and colleagues examined the risk for liver cancer for

HealthDay 30 July at 08.59 PM

CDC: Despite Wanting to Quit, Only 8.8 Percent Quit Smoking in 2022

Although about two-thirds of U.S. adults who smoked wanted to quit, only 8.8 percent of smokers quit in 2022, according to research published in the July 25 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Brenna VanFrank, M.D., from the CDC in Atlanta, and colleagues used 2022 National

HealthDay 30 July at 09.57 AM

FDA Warns of Accidental Overdoses From Compounded Versions of Ozempic

People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns.These ODs typically are due to miscommunications or miscalculations regarding dosage, the FDA added.“Dosing errors have res

HealthDay 29 July at 09.30 PM

Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder

For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures compared with other antidiabetes medications, according to a study published online July 30 in the Annals of Internal Medicine.William Wang, from the Case Western Rese

HealthDay 29 July at 03.30 PM

Study Looks at Effects of Reducing Intake of Processed Meat, Unprocessed Red Meat

Reductions in processed meat and unprocessed red meat consumption could result in fewer occurrences of type 2 diabetes, cardiovascular disease, colorectal cancer, and all-cause deaths, according to a study published in the July issue of The Lancet Planetary Health.Joe Kennedy, Ph.D., from the University of Edinburgh in the United Kingdo

HealthDay 26 July at 03.48 PM

GLP1RAs Tied to Greater Risk of Diabetic Retinopathy Progression Than SGLT2is

In patients with diabetes and established diabetic retinopathy (DR), treatment with glucagon-like peptide 1 receptor agonists (GLP1RAs) is associated with increased risks of DR progression compared with sodium-glucose cotransporter 2 inhibitors (SGLT2is), according to a study published online July 19 in&nbsp;Diabetes, Obesity and Metabolism.</

HealthDay 26 July at 10.45 AM

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3 sensors that may provide incorrect high glucose readings, which if undetected may pose a potential health risk for people living

HealthDay 25 July at 03.33 PM

Childhood Type 1 Diabetes Tied to Higher Risk of Later Psychiatric Diagnoses

A childhood diagnosis of type 1 diabetes (T1D) may increase risk of later psychiatric conditions, according to a study published online July 17 in&nbsp;Nature Mental Health.Tomáš Formánek, from the University of Cambridge in the United Kingdom, and colleagues used Czech national register data to identify children (aged ≤14 years) with

HealthDay 23 July at 10.27 PM

Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia

The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of the&nbsp;Annals of Family Medicine.Hsiang-Ju Cheng, M.D., from the National Cheng Kung University in Tainan, Taiwan, and colleagues investigated the relationship bet

HealthDay 23 July at 03.45 PM

Link Between T2DM, Spinal Degenerative Disorder May Be Method-Dependent

The association between type 2 diabetes mellitus (T2DM) and spinal degenerative disorders (SDDs) may be method-dependent, according to a study published online July 3 in The Journal of Bone &amp; Joint Surgery.Ming-Xiang Zou, M.D., Ph.D., from the University of South China in Hengyang, and colleagues examined and compared the associati

HealthDay 22 July at 09.49 PM

2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions

From 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a research letter published online July 23 in the Annals of Internal Medicine.Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined nationwide trends in GLP-1RA prescription

HealthDay 19 July at 03.59 PM

Sleep Apnea Increases Risk for Cardiovascular Risk Factors and Events

Obstructive sleep apnea (OSA) is associated with an increased risk for cardiovascular disease (CVD) in adults, even those younger than 40 years, according to a study published online June 6 in the&nbsp;Journal of the American Heart Association.Chance Strenth, Ph.D., from University of Texas Southwestern Medical Center Dallas, and collea

HealthDay 19 July at 03.46 PM

Irregular Sleep Duration Tied to Increased Risk for Developing Diabetes

Irregular sleep duration is associated with elevated diabetes risk, according to a study published online July 17 in Diabetes Care.Sina Kianersi, Ph.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the association between irregular sleep duration and incident diabetes among 84,421 U.K.

HealthDay 18 July at 03.46 PM

Accelerated Progression to T1D During Pandemic Seen for Presymptomatic Youth

For youth with presymptomatic type 1 diabetes, the COVID-19 pandemic was associated with accelerated progression to clinical disease, especially among those with COVID-19 infection, according to a research letter published online July 15 in the Journal of the American Medical Association.Nadine Friedl, from the Institute of Diabetes R

HealthDay 17 July at 03.14 PM

Aging Into Medicare Tied to Higher Drug Costs for People With Diabetes

As people with diabetes age into Medicare, they face increased quarterly out-of-pocket costs for medication, according to a study published online July 9 in&nbsp;JAMA Network Open.Douglas Barthold, Ph.D., from the University of Washington in Seattle, and colleagues examined whether reaching age 65 years is associated with changes in

HealthDay 16 July at 03.29 PM

Suicidal Ideation, Behaviors Not Increased With GLP-1 RAs for Seniors With T2D

For older adults with type 2 diabetes (T2D), use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is not associated with a significantly increased risk for suicidal ideation and behaviors, according to a study published online July 16 in the Annals of Internal Medicine.Huilin Tang, from the University of Florida College of Phar

HealthDay 16 July at 03.26 PM

Certain Diets May Protect Against Heart Disease With Type 1 Diabetes

Certain dietary patterns may protect against inflammation and heart disease in adults with type 1 diabetes, according to a study presented during NUTRITION 2024, the annual meeting of the American Society for Nutrition, held from June 29 to July 2 in Chicago.Arpita Basu, Ph.D., from the University of Nevada in Las Vegas, and colleagues used dat

HealthDay 15 July at 10.00 PM

Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk

Compared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk, according to a review published online May 3 in the American Journal of Preventive Medicine.Yongjun Sunwoo, from the College of Pharmacy at Kyung Hee University in Seoul, South Korea, an

HealthDay 12 July at 10.21 PM

More Women Than Men Experience Nonphysical Violence in Health Care Workforce

Women in the health care workforce are more likely to experience verbal abuse, sexual harassment, and bullying, while men are more likely to experience physical violence, according to a study published online July 2 in PLOS Global Public Health.Sioban Nelson, R.N., Ph.D., from the University of Toronto, and colleagues conducted a scopin

HealthDay 12 July at 10.16 PM

Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later

Three of four patients stop taking semaglutide (Ozempic or Wegovy) two years after being prescribed the glucagon-like peptide-1 receptor agonist (GLP-1 RA) for weight loss, according to new analysis conducted by Prime Therapeutics and Magellan Rx Management (MRx).For the review, pharmacy and medical claims data for 3,364 people with insurance pl

HealthDay 12 July at 03.25 PM

Parents' Weight Status at Age 17 Correlates to Offspring Weight at 17

The weight status of parents at 17 years of age is associated with obesity risk for both female and male offspring, according to a study published online June 28 in&nbsp;JAMA Network Open.Gabriel Chodick, Ph.D., from Tel Aviv University in Israel, and colleagues assessed the heritability of obesity. The analysis included 447,883 offspri

HealthDay 12 July at 12.36 PM

New Report Calls for More Research on Women's Health Issues

A new report finds research is sorely lacking on how chronic illnesses affect women, and it urged government agencies to do more to investigate how these diseases strike women differently.The National Academies of Sciences, Engineering and Medicine <a href="https://nap.nationalacademies.org/catalog/27757/advancing-research-on-chronic-conditions-

HealthDay 11 July at 04.04 PM

GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2D

For patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine

HealthDay 11 July at 03.40 PM

Testosterone Tied to Incidence, Progression of Metabolic Syndrome

Testosterone is associated with a greater risk for development and progression of metabolic syndrome, particularly in transmasculine individuals, according to a study published online July 2 in&nbsp;JAMA Network Open.Leila Hashemi, M.D., from the David Geffen School of Medicine in Los Angeles, and colleagues assessed whether gender-af

HealthDay 10 July at 03.58 PM

Study Looks at Impact of Incentivizing Smoking Cessation in Addition to Usual Care

Incentivizing smoking cessation increases smoking cessation through 12 weeks, but not at 26 weeks, when missing data are treated as smoking, according to a study published online July 2 in JAMA Network Open.Darla E. Kendzor, Ph.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues randomly assign

HealthDay 10 July at 03.18 PM

Delaying Diabetes Progression After Impaired Glucose Improves Long-Term Outcomes

Maintaining several years of nondiabetes status after impaired glucose tolerance (IGT) diagnosis is associated with a significantly lower risk for poor long-term outcomes, according to a study published online July 9 in&nbsp;PLOS Medicine.Xin Qian, from the Chinese Academy of Medical Sciences and Peking Union Medical College in Beiji

HealthDay 09 July at 03.42 PM

Semaglutide Cuts MACE in People With Overweight, Obesity, Regardless of HbA1c

Semaglutide reduces cardiovascular events, regardless of baseline glycated hemoglobin (HbA1c), among people with overweight or obesity and established atherosclerotic cardiovascular disease, according to a study published online June 22 in Diabetes Care.Ildiko Lingvay, M.D., from the University of Texas Southwestern Medical Center in Da

HealthDay 08 July at 09.38 PM

Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide

Tirzepatide is associated with significantly greater weight loss than semaglutide for adults with overweight or obesity, according to a study published online July 8 in JAMA Internal Medicine.Patricia J. Rodriguez, Ph.D., from Truveta Inc. in Bellevue, Washington, and colleagues compared on-treatment weight loss and rates of gastrointest

HealthDay 05 July at 02.26 PM

Postpandemic Physician Revenue Recovery Varies by Specialty, Practice Type

Pandemic-associated physician revenue recovery in 2021 and 2022 varied by specialty and practice type, according to a study published in the July issue of&nbsp;Health Affairs.Ravi B. Parikh, M.D., from the University of Pennsylvania in Philadelphia, and colleagues assessed pandemic-related impact on physician revenue (2020 to 2022) and h

HealthDay 03 July at 08.32 PM

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with overweight/obesity, according to a study published online July 3 in JAMA Ophthalmology.Jimena Tatiana Hathaway, M.D., M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and

HealthDay 03 July at 12.21 PM

FDA Bans Food Additive Found in Sports Drinks, Sodas

A regulation allowing the use of brominated vegetable oil in food was revoked Tuesday by the U.S. Food and Drug Administration after the agency concluded the additive was unsafe for human consumption.Brominated vegetable oil (BVO) contains bromine, which is found in fire retardants. Small quantities of BVO have been used legally in some citrus

HealthDay 02 July at 04.01 PM

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are considered, according to a study published online June 28 in&nbsp;JAMA Network Open.Aylin Sertkaya, Ph.D., from Eastern Research Group Inc., in Lexington, Massachusetts, and colleagues ass

HealthDay 01 July at 05.50 PM

American Diabetes Association, June 21-24

The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances in di

HealthDay 01 July at 03.33 PM

Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening

Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published online June 26 in JAMA Network Open.Daniel Edmonston, M.D., from the Duke University School of Medicine in Durham, North Carolina, and colleagues conducted a retrospective cohort study t

HealthDay 27 June at 03.21 PM

ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity

Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Adam Seal, Ph.D., from the California Polytechnic State University in San Luis Obispo, and collea

HealthDay 27 June at 03.16 PM

ADA: Inhaled Insulin Shows Promise for Adults With Type 1 Diabetes

Inhaled insulin is associated with improved hemoglobin A1c (HbA1c) levels over 16 weeks among adults with type 1 diabetes when compared to usual care, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.Irl B. Hirsch, M.D., from the University of Washington in S

HealthDay 26 June at 03.26 PM

ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure

For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar improvements in heart failure-related symptoms in men and women, according to a study published online June 23 in the Journal of the American College of Cardiology to coinc

HealthDay 26 June at 03.26 PM

ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA

Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online June 21 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 21 to 24 in Orlando, Florida.At

HealthDay 26 June at 03.25 PM

Dysbiosis in Phylogenetically Diverse Species Associated With Type 2 Diabetes

The gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study published online June 25 in Nature Medicine.Zhendong Mei, Ph.D., from Brigham and Women's Hospital in Boston, and colleagues analyzed 8,117 shotgun metagenomes from 10 cohorts of individuals with T2D, prediabetes, and

HealthDay 25 June at 03.01 PM

Intermittent Fasting Aids Early Diabetes Outcomes More Than Drugs

Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or overweight, according to a study published online June 21 in&nbsp;JAMA Network Open.Lixin Guo, M.D., from the Chinese Academy of Medical Sciences in Beijing, and colleagues evaluated the effect of intermittent fasti

HealthDay 24 June at 03.23 PM

U.S. Supreme Court Agrees to Hear Case on Medical Care for Transgender Youth

The U.S. Supreme Court announced Monday that it would hear a case on a Tennessee law that bans transgender minors from receiving certain medical treatments in that state.The banned treatments include puberty-blocking drugs or hormonal therapies.It's the

HealthDay 24 June at 03.15 PM

Acupuncture Reduces Endocrine Symptoms, Hot Flashes in Breast Cancer

A 10-week acupuncture intervention significant reduces endocrine symptoms and hot flashes among women with breast cancer receiving endocrine therapy (ET), according to a study published online June 24 in Cancer.Weidong Lu, M.P.H., Ph.D., from the Dana Farber Cancer Institute in Boston, and colleagues enrolled 158 patients with stage 0 t

HealthDay 21 June at 03.36 PM

Timing of Metformin Important in Metformin-Treated Type 2 Diabetes

Glucose lowering by metformin is greater when given before enteral glucose among patients with type 2 diabetes controlled by metformin monotherapy, according to a study recently published in Diabetologia.Cong Xie, Ph.D., from the University of Adelaide in Australia, and colleagues studied 16 participants with type 2 diabetes that was re

HealthDay 21 June at 11.43 AM

WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

Both the World Health Organization and Eli Lilly warned Thursday that consumers should avoid fake versions of weight-loss drugs that are circulating in numerous countries.The WHO warning said that the inter

HealthDay 20 June at 08.56 PM

2021 to 2022 Saw Decrease in Telemedicine Use in Past 12 Months

From 2021 to 2022, there was a decrease in the percentage of adults who used telemedicine in the past 12 months, according to the June 20 National Vital Statistics Reports, a publication from the National Center for Health Statistics.Jacqueline W. Lucas, M.P.H., and Xun Wang, from the National Center for Health Statistics in Hyattsvil

HealthDay 20 June at 08.50 PM

Timing of Exercise Significant for Obesity, Metabolic Impairment

For sedentary adults with obesity/overweight and metabolic impairments, the timing of moderate-to-vigorous physical activity (MVPA) is significant, with a beneficial effect on glucose homeostasis for accumulation of more MVPA in the evening, according to a study published online June 10 in Obesity.Antonio Clavero-Jimeno, from the Univ

HealthDay 20 June at 03.46 PM

Endocrine Society, June 1-4

The annual meeting of the Endocrine Society (ENDO 2024) was held from June 1 to 4 in Boston, attracting approximately 7,000 participants, including clinicians, academicians, allied health professionals, and others interested in endocrine and metabolic disorders. The conference highlighted recent advances in the diagnosis and

HealthDay 19 June at 04.04 PM

Type of Educational Institution Attended Linked to Health Outcomes

The type of educational institution attended is associated with multiple health outcomes in midlife, according to a study published online June 18 in the Journal of Epidemiology &amp; Community Health.Keyao Deng, from University College London, and colleagues examined associations between the type of high school or university attende

HealthDay 19 June at 03.43 PM

Benefits of Roux-en-Y Gastric Bypass Sustained in the Long Term

Roux-en-Y gastric bypass (RYGB) is successful in achieving long-term sustained weight loss and diabetes remission, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylva

HealthDay 18 June at 09.11 PM

Approximately 7 Percent of U.S. Population Uninsured in 2023

In 2023, 7.6 percent of the U.S. civilian noninstitutionalized population was uninsured, according to early estimates from the National Health Interview Survey, 2023, released by the National Center for Health Statistics.Robin A. Cohen, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues used data from

HealthDay 18 June at 03.32 PM

Continuing Metformin in Pregnancy Has Little Effect on Nonlive Birth

Continuing metformin and adding insulin in early pregnancy does not significantly alter the risk for nonlive birth or live birth with congenital malformations compared with switching to insulin monotherapy, according to a study published online June 18 in the Annals of Internal Medicine.Yu-Han Chiu, M.D., Sc.D., from the Harvard T.H. C

HealthDay 18 June at 09.50 AM

Pandemic-Era Tax Credits Made Healthcare More Affordable, But They're Set to Expire

In a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found.Trouble is, the credits are set to expire at the end of 2025, noted a research team from the nonprofit Robert Wood Johnson Foundation (RWJ).According to RWJ's <a h

HealthDay 17 June at 10.55 PM

Paternal Metformin Use Not Linked to Major Congenital Malformations

Paternal use of metformin in monotherapy is not associated with an increased risk for major congenital malformations (MCMs), according to a study published online June 18 in the Annals of Internal Medicine.Ran S. Rotem, Sc.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined the association between p

HealthDay 17 June at 10.53 PM

1999 to 2020 Saw Diet Quality Improve Among U.S. Adults

From 1999 to 2020, diet quality improved among U.S. adults, according to a study published online June 18 in the Annals of Internal Medicine.Junxiu Liu, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and Dariush Mozaffarian, M.D., Dr.P.H., from Tufts University in Boston, examined trends in diet quality by rac

HealthDay 17 June at 10.51 PM

Meal Replacement + Financial Incentives Beneficial for Teens With Obesity

For adolescents with severe obesity, meal replacement therapy (MRT) plus financial incentives (FIs) yield a greater reduction in body mass index (BMI) and total body fat mass than MRT alone, according to a study published online June 17 in JAMA Pediatrics.Amy C. Gross, Ph.D., from the University of Minnesota Center for Pediatric Obesity

HealthDay 17 June at 03.37 PM

Bariatric Surgery Cuts Conversion to Diabetes Over Long-Term Follow-Up

Bariatric surgery significantly decreases the conversion from prediabetes to type 2 diabetes, according to a study presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 9 to 13 in San Diego.John Nguyen-Lee, M.D., from the Geisinger Medical Center in Danville, Pennsylvania, and colleagues eval

HealthDay 14 June at 03.34 PM

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online June 12 in The BMJ.Kaijie Yang, from the First Hospital of China Medical University in Shenyang, and colleagues estimated the burden, trends, and inequalities of T1DM among older adults

HealthDay 13 June at 10.58 PM

Health Care Spending Growth Projected to Outpace GDP to 2032

Health care spending growth is projected to outpace that of the gross domestic product (GDP) during the coming decade, according to a study published online June 12 in Health Affairs.Jacqueline A. Fiore, Ph.D., from the Centers for Medicare &amp; Medicaid Services in Baltimore, and colleagues projected growth in national health expend

HealthDay 12 June at 10.42 PM

Adverse Social Determinants of Health Linked to Prediabetes in Teens

Adverse social determinants of health (SDOH) are associated with higher prevalence of prediabetes among adolescents, according to a study published online June 11 in JAMA Network Open.Caleb Harrison, from the UPMC Children's Hospital of Pittsburgh, and colleagues examined the prevalence of prediabetes by presence or absence of advers

HealthDay 12 June at 03.05 PM

Adverse Effects of Medical Treatment Increasing Worldwide

The burden of adverse effects of medical treatment (AEMT) is increasing, with the proportion of all cases accounted for by the increasing rates seen in older adults, according to a study published online June 11 in BMJ Quality &amp; Safety.Liangquan Lin, from the Chinese Academy of Medical Sciences &amp; Peking University Medical Col

HealthDay 12 June at 02.52 PM

ENDO: Novel Male Contraceptive Gel May Achieve Faster Sperm Suppression

A novel male contraceptive gel suppresses sperm production faster than other hormone-based methods for male birth control, according to a phase 2 study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Danielle Gross, from the Eunice Kennedy Shriver National Institute of Child Health and Human Developme

HealthDay 11 June at 03.45 PM

ENDO: Teprotumumab Shows Long-Term Efficacy for Thyroid Eye Disease

Most patients with thyroid eye disease treated with teprotumumab do not require additional treatments nearly two years later, according to a study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston, and simultaneously published online June 2 in&nbsp;Thyroid.George J. Kahaly, M.D., Ph.D., from the

HealthDay 11 June at 03.42 PM

ENDO: Early Menopause Tied to Heightened Risk for Breast, Ovarian Cancer

Women with early menopause have a two times greater risk for breast cancer and a nearly four times higher risk for ovarian cancer, according to a study presented at the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Kristina&nbsp;L. Allen-Brady, Ph.D., M.P.H., from University of Utah in Salt Lake City, and colleagues i

HealthDay 10 June at 09.50 PM

Insulin-Treated T2D Patients Unwilling to Participate in Intensive Lifestyle Intervention

For adults with advanced, insulin-treated type 2 diabetes (T2D), willingness to participate in an intensive lifestyle intervention (ILI) is very low, according to a research letter published online June 5 in Diabetes, Obesity and Metabolism.Cathy J. Sun, M.D., from The Ottawa Hospital in Ontario, Canada, and colleagues designed an ILI p

HealthDay 10 June at 03.28 PM

Greater Reduction Seen in Mortality With Bariatric Surgery Than GLP-1 RAs

Bariatric metabolic surgery (BMS) is associated with a greater reduction in mortality than glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment among adults with a diabetes duration of 10 years or less, according to a study published online June 7 in JAMA Network Open.Dror Dicker, M.D., from Rabin Medical Center in Petah Tikva,

HealthDay 10 June at 03.22 PM

Vitamin D Suggested for Children, Seniors, Those With High-Risk Prediabetes

Empiric vitamin D supplementation is suggested for those aged 1 to 18 years, those older than 75 years, those who are pregnant, and those with high-risk prediabetes, according to an Endocrine Society clinical practice guideline published online June 3 in the Journal of Clinical Endocrinology &amp; Metabolism.Marie B. Demay, M.D., from M

HealthDay 07 June at 03.34 PM

ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease

For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i) are associated with reduced risk of cardiovascular (CV) events compared with dipeptidyl peptidase 4 inhibitors (DPP-4i), according to a st

HealthDay 07 June at 03.33 PM

Isotretinoin Effective for Acne in Those Receiving Gender-Affirming Therapy

Isotretinoin is well tolerated and effective for individuals receiving masculinizing gender-affirming hormonal therapy who have acne, according to a study published online May 29 in JAMA Dermatology.James Choe, from Brigham and Women's Hospital in Boston, and colleagues examined clinical outcomes of isotretinoin among transgender and gen

HealthDay 07 June at 03.31 PM

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according to a study published online June 6 in PLOS Medicine.Wei Zhou, from Shandong University in Jinan, China, and colleagues compared the metabolic profiles of children born after frozen ve

HealthDay 06 June at 03.55 PM

Smoking Cessation Aids Equally Effective in Those With Mental Health Conditions

Popular smoking cessation aids are equally effective in those with or without a history of mental health conditions, according to a study published online June 4 in&nbsp;PLOS Mental Health.Sarah E. Jackson, Ph.D., from University College London, and colleagues examined whether the real-world effectiveness of popular smoking cessation a

HealthDay 05 June at 03.23 PM

ENDO: Crinecerfont Aids Patients With Congenital Adrenal Hyperplasia

Crinecerfont results in a greater decrease from baseline in the mean daily glucocorticoid dose among patients with congenital adrenal hyperplasia (CAH), according to a study published online June 2 in the New England Journal of Medicine to coincide with the annual meeting of the Endocrine Society, held from June 1 to 4 in Boston.Richa

HealthDay 04 June at 10.28 PM

Excess Mortality Persisted in Western World From 2020 Through 2022

Excess mortality persisted in 2020 through 2022 in the Western world, according to a study published online June 3 in BMJ Public Health.Saskia Mostert, M.D., from Amsterdam UMC, and colleagues explored excess mortality in the Western world from 2020 to 2022 using all-cause mortality reports abstracted from the "Our World in Data" databa

HealthDay 04 June at 03.49 PM

Diabetes Tied to Higher Prevalence of Overactive Bladder

Markers of diabetes are positively associated with overactive bladder (OAB), according to a study published online April 28 in&nbsp;Frontiers in Endocrinology.Qingliu He, from Jinjiang Municipal Hospital in Quanzhou, China, and colleagues used data from six cycles of the U.S. National Health and Nutrition Examination Survey (23,863 part

HealthDay 03 June at 09.12 PM

9.6 Percent of Medical Visits Took Place Via Telehealth in 2021

In 2021, 9.6 percent of medical visits took place via telehealth, with a higher percentage seen for mental health visits, according to a research letter published online June 4 in the Annals of Internal Medicine.Sandra L. Decker, Ph.D., from the Agency for Healthcare Research and Quality in Rockville, Maryland, and colleagues describe te

HealthDay 03 June at 03.53 PM

Plozasiran Reduces Triglyceride Levels in Mixed Hyperlipidemia

For individuals with mixed hyperlipidemia, plozasiran reduces triglyceride levels at 24 weeks, according to a study published online May 28 in the New England Journal of Medicine.Christie M. Ballantyne, M.D., from the Baylor College of Medicine and Texas Heart Institute in Houston, and colleagues conducted a 48-week, randomized trial ass

HealthDay 31 May at 03.49 PM

BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults

The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented at the annual meeting of the European Congress on Obesity, hosted by the European Association for the Study of Obesity from May 12 to 15 in Venice, Italy.Marwan El Ghoch, M.D., from

HealthDay 31 May at 03.43 PM

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from cardiovascular causes, according to a study published online May 24 in the New England Journal of Medicine to coincide with the annual European Renal Association Congress, held from May 23 to 26 in S

HealthDay 31 May at 03.41 PM

Weight Navigation Program Boosts Use of Weight Management Treatments

A primary care-based weight navigation program (WNP) is feasible and associated with greater use of weight management treatments (WMT) and weight loss, according to a study published online May 21 in JAMA Network Open.Dina H. Griauzde, M.D., from the University of Michigan Medical School in Ann Arbor, and colleagues examined the associat

MedScape 30 May at 07.59 AM

Novel Score Predicts Weight Loss With Semaglutide in T2D

The individualized metabolic surgery score could help set realistic weight loss targets with semaglutide in patients with type 2 diabetes and obesity.

HealthDay 29 May at 09.17 PM

2007 to 2019 Saw Increase in Inflation-Adjusted Health Care Spending

From 2007 to 2019, there was an increase in inflation-adjusted health care spending, largely due to increasing contributions to premiums, according to a research letter published online May 28 in JAMA Internal Medicine.Sukruth A. Shashikumar, M.D., from the Beth Israel Deaconess Medical Center in Boston, and colleagues conducted a cro

HealthDay 29 May at 03.06 PM

Demographic, Clinical, Financial Factors Tied to GLP-1 Agonist Discontinuation

Specific demographic, clinical, and financial characteristics are associated with glucagon-like peptide 1 (GLP-1) receptor agonist discontinuation, according to a research letter published online May 24 in&nbsp;JAMA Network Open.Duy Do, Ph.D., from the Evernorth Research Institute in St. Louis, and colleagues estimated the prevalence

MedScape 29 May at 09.42 AM

Can Curbing Sedentary Habits Mitigate Mortality Risk in T2D?

Patients with T2D who were sedentary for less than 6 hours a day had reduced mortality risk, and moderate physical activity enhanced longevity in those with more sedentary habits.

MedScape 29 May at 01.35 AM

Add-On to GLP-1s Yields Greater Weight Loss

Combination therapy of bupropion/naltrexone and GLP-1 receptor agonists showed a synergistic weight loss effect in individuals with obesity who responded poorly to GLP-1 monotherapy.

MedScape 28 May at 06.09 AM

How Can Patients With Diabetes and Obesity Lose Weight?

At a recent diabetes conference, experts debated the relative merits of exercise and medication for weight loss in this patient population.

MedScape 28 May at 06.04 AM

Analysis-Weight-loss Drug Forecasts Jump to $150 Billion as Supply Grows

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading...

MedScape 27 May at 06.41 AM

CGM Aids in Detecting Early Gestational Diabetes

Glycemic patterns detected by continuous glucose monitoring (CGM) may help diagnose gestational diabetes earlier in pregnancy, which may help improve perinatal outcomes.

MedScape 25 May at 12.03 PM

Advisory Panel Votes Against Once-Weekly Insulin for T1D

A majority of the advisory committee voted that the benefits of insulin icodec don't outweigh the increased risk of hypoglycemia in type 1 diabetes.

HealthDay 24 May at 03.56 PM

Prenatal Exposure to Endocrine-Disrupting Chemicals Affects Child's Metabolic Health

Prenatal exposure to endocrine-disrupting chemicals (EDCs) is associated with adverse metabolic health in children, according to a study published online May 23 in JAMA Network Open.Nuria Güil-Oumrait, from the Barcelona Institute for Global Health in Spain, and colleagues examined associations of prenatal exposure to EDC mixtures with t

MedScape 24 May at 08.19 AM

Losing Muscle with GLP-1 RAs? There May be a Drug for That

Agents in development would preserve lean body mass and further promote fat loss in people taking new antiobesity medications for weight loss.

MedScape 23 May at 09.00 AM

More Weight Loss With Anti-Obesity Meds and Hormone Therapy?

Women who take hormone therapy showed a better response to GLP-1 drugs and lost more weight.

MedScape 23 May at 07.38 AM

Potential Precursor Lesion to Adrenal Tumors Identified

CPAs are the result of gene mutations leading to the development of two-layer nodules that have tumor-inducing and suppressing effects, suggested a new study.

HealthDay 22 May at 04.11 PM

GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults

For adolescents and young adults, glucagon-like peptide-1 receptor agonist (GLP-1 RA) dispensing increased from 2020 to 2023, according to a research letter published online May 22 in the Journal of the American Medical Association.Joyce M. Lee, M.D., M.P.H., from the University of Michigan Medical School in Ann Arbor, and colleagues

HealthDay 22 May at 03.50 PM

Global Life Expectancy, Disease Burden Set to Keep Improving

Life expectancy and age-standardized disease burden are expected to continue improving between 2022 and 2050, according to the Global Burden of Disease (GBD) study, published in the May 18 issue of The Lancet.Stein Emil Vollset, M.D., M.P.H., and colleagues from the GBD 2021 Forecasting Collaborators provide a reference forecast and a

MedScape 22 May at 09.00 AM

Cortisol Test Confirms HPA Axis Recovery from Steroid Use

Early serum cortisol > 237 nmol/L validated as a screen for predicting the recovery of the HPA axis in patients on tapering regimes from long‐term chronic glucocorticoid therapy.

MedScape 22 May at 05.24 AM

Are Secondary Osteoporosis Causes Under-Investigated?

A single-center chart review found that postmenopausal women with osteoporosis may be started on antiresorptive therapy without having had secondary causes ruled out.

MedScape 22 May at 02.53 AM

Do Texts With Financial Incentives Aid Weight Loss in Men?

Text messages with financial incentives for men with obesity led to nearly two thirds losing 5% body weight over a year, and many men were from socially deprived groups.

MedScape 21 May at 09.05 AM

Social Media a 'Powerful' Way to Talk to Teens About Obesity

A short semaglutide video on TikTok drew close to 1 million views.

MedScape 21 May at 08.06 AM

Does Daytime Hypoglycemia Contribute to Impaired Awareness?

In older adults with T1D, less daytime hypoglycemia was the biggest predictor of improvements in IAH in a 6-month study.

MedScape 21 May at 07.04 AM

Nestle Set to Sell $5 Pizza, Sandwiches for Wegovy, Ozempic Users

Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as...

MedScape 21 May at 06.18 AM

Food Insecurity Quadruples Severe Hypoglycemia Risk in T2D

Both financial and physical food insecurity increased the risk, but standard questions didn't capture the latter.

HealthDay 20 May at 10.32 PM

Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes

Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by the European Society of Endocrinology from May 11 to 14&nbsp;in Stockholm.Angelica Lindén Hirschberg, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleague

HealthDay 20 May at 10.30 PM

Arm Fat May Predict Spinal Fracture Risk

Arm fat may predict risk for spinal fracture, according to a study presented at the annual European Congress of Endocrinology, hosted by the European Society of Endocrinology from May 11 to 14&nbsp;in Stockholm.Maria Eleni Chondrogianni, from the National and Kapodistrian University of Athens in Greece, and colleagues investigated the association

HealthDay 20 May at 03.47 PM

Guideline Developed for Glucocorticoid-Induced Adrenal Insufficiency

In a clinical guideline issued jointly by the European Society of Endocrinology and the Endocrine Society, recommendations are presented for the diagnosis and management of glucocorticoid-induced adrenal insufficiency. The guideline was published online May 8 simultaneously in the European Journal of Endocrinology and the Journal of Clinica

HealthDay 20 May at 03.44 PM

Blood Sugar Levels at Gestational Diabetes Diagnosis Predict Outcomes

Glucose above the diagnostic threshold at the time of gestational diabetes diagnosis is associated with worse neonatal outcomes, according to a study presented at the annual European Congress of Endocrinology, hosted by the European Society of Endocrinology from May 11 to 14&nbsp;in Stockholm.Catarina Cidade-Rodrigues, M.D., from Centro Hospitala

HealthDay 17 May at 08.59 PM

Slight Body Mass Gains in Middle Age May Cut Later Fracture Risk

People whose body mass index (BMI) slightly increases from normal weight to low-level overweight during 30 years of middle adulthood have a lower risk for fracture in later life, according to a study published online April 8 in&nbsp;Osteoporosis International.Zihao Xin, from the Boston University School of Public Health, and colleagues e

HealthDay 17 May at 04.27 PM

Men Face More Diabetes Complications Than Women

Men with diabetes have a greater risk for complications than women, irrespective of diabetes duration, according to a study published online May 16 in the&nbsp;Journal of Epidemiology &amp; Community Health.Alice A. Gibson, from the University of Sydney, and colleagues investigated sex differences in incident microvascular and macrovascu

MedScape 17 May at 08.22 AM

Why Insulin Resistance Is Higher in Men With Obesity?

In comparing women and men with obesity, researchers proposed that the latter are more insulin resistant due to less efficient inhibition of fat cell lipolysis.

MedScape 17 May at 05.04 AM

Switching Technologies in T1D May Offer Glycemic Benefit

An AID system improved glycemic outcomes in adults with long-standing T1D who struggled to meet their glycemic targets using insulin pumps and CGM.

MedScape 17 May at 04.05 AM

Cellular Therapy for Diabetes: What Progress Has Been Made?

Research into micro-, nano-, and macroencapsulation has led to historic moments, according to an expert endocrinologist.

MedScape 17 May at 03.09 AM

Does Eating Food With Emulsifiers Increase T2D Risk?

Food emulsifiers, a common ingredient in many ultraprocessed foods consumed by millions worldwide, increased the risk for incident type 2 diabetes.

HealthDay 16 May at 04.01 PM

Activity Tracker, Scale Plus Phone App May Aid Weight Loss

Weight loss is similar for individuals using a wireless feedback system (WFS) that provides daily information on lifestyle change and weight loss versus the same system augmented with human coaching, according to a study published online May 14 in the&nbsp;Journal of the American Medical Association. The research was published to coincide wit

MedScape 16 May at 11.17 AM

Is Body Fat a Better Measure of Obesity in Midlife Than BMI?

The conventional BMI cutoff for obesity may be better replaced with adiposity measures that accommodate changes in the body fat-to-muscle ratio that changes in the midlife years.

MedScape 16 May at 09.05 AM

Survey Suggests 1 in 8 US Adults May Have Used a GLP-1 Drug

A KFF poll also suggests half of the respondents who had tried these weight loss meds no longer took them, with many reporting difficulties paying for these drugs.

MedScape 16 May at 08.46 AM

Collaboration Tackles Steroid-Induced Adrenal Insufficiency

Best management practice for glucocorticoid-induced adrenal insufficiency has been developed jointly by endocrinologists in Europe and the United States.

MedScape 16 May at 06.45 AM

Lilly's Once-Weekly Insulin Top-Line Results Show Benefit

Phase 3 data for efsitora alfa showed noninferiority to once-daily basal insulins in two studies of people with type 2 diabetes.

HealthDay 15 May at 08.58 PM

Widening Disparities Seen in Youth Obesity

In the 2019 to 2020 school year, 20.9 percent of New York City elementary and middle school students had obesity, and 6.4 percent had severe obesity, according to a study published online May 15 in&nbsp;PLOS ONE.Kira L. Argenio, M.P.H., from the New York City Department of Health and Mental Hygiene, and colleagues estimated the preval

HealthDay 15 May at 03.40 PM

Text Messages + Financial Incentives Boost Weight Loss at 12 Months

Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group, according to a study published online May 14 in the&nbsp;Journal of the American Medical Association&nbsp;to coincide with the annual meeting of the European Congress on Obesity, hosted by the

HealthDay 15 May at 03.33 PM

AI-Informed Health App Aids Diabetes Outcomes

Use of an artificial intelligence (AI)-informed health app aids diabetes outcomes and cuts atherosclerotic cardiovascular disease (ASCVD) risk, according to a study presented at the annual meeting of the American Association of Clinical Endocrinology, held from May 9 to 11 in New Orleans.Paramesh Shamanna, M.D., from the Bangalore Diabetes Cent

HealthDay 15 May at 03.23 PM

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in&nbsp;Diabetes, Obesity, and Metabolism.Osvaldo P. Almeida, Ph.D., from University of Notre Dame in Fremantle, Australia, and colleagues assessed whet

MedScape 15 May at 09.04 AM

No Added Weight Loss Benefits Switching Healthy Diets?

Switching from one healthy weight loss diet to another did not overcome the typical weight loss plateau at 6 months in individuals with overweight and obesity.

MedScape 15 May at 08.14 AM

Tackling Lean Mass Loss When Weight Loss is Successful

The loss of lean mass has become a hot topic with new anti-obesity drugs, but such changes can occur with most successful weight loss interventions — without meaningful countermeasures.

MedScape 15 May at 05.14 AM

Setmelanotide Shows Promise in Hypothalamic Obesity

Treatment with setmelanotide, a melanocortin-4 receptor agonist, led to a significant reduction in BMI in a difficult-to-treat population of patients with hypothalamic obesity.

MedScape 15 May at 01.56 AM

No Shortage Of Wegovy Weight-loss Drug in Denmark, Novo Nordisk Says

Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two...

HealthDay 14 May at 10.41 PM

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to the results of a new KFF Health Tracking Poll, released May 10.Alex Montero, from KFF Health, and colleagues analyzed data collected April 23 to May 1, 2024, online and by te

MedScape 14 May at 05.58 PM

Eli Lilly Reaches Settlement With Spa Selling Mounjaro, Zepbound Knockoffs

Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit versions of its popular diabetes drug Mounjaro and weight loss treatment Zepbound, the...

HealthDay 14 May at 03.54 PM

Most Slow Responders to Tirzepatide Do Lose Clinically Meaningful Weight

Among slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically meaningful weight reduction (≥5 percent) by week 72, according to a study presented at the annual meeting of the American Association of Clinical Endocrinology, held from May 9 to 11 in New Orleans.Kimberly Gudzune, M.D., from Johns Hopkins Univer

MedScape 14 May at 01.28 PM

Semaglutide CV Benefits Irrespective of Weight Lost?

Semaglutide remains effective for weight loss at 4 years in people with preexisting cardiovascular disease and overweight/obesity but without T2D and provides CV benefits regardless of weight.

MedScape 14 May at 10.43 AM

Weight Loss Maintained With Slow Taper of Semaglutide

A digital lifestyle program used in combination with semaglutide from low starting dose shows participants can maintain weight loss after tapering and stopping the drug, irrespective of starting BMI.

MedScape 14 May at 09.47 AM

Bone Quality Key in Mild Autonomous Cortisol Secretion

Small study finds that adrenalectomy improves bone quality but not density in MACS, suggesting that the former is key to the increased fracture risk in the condition.

MedScape 14 May at 05.59 AM

Does Childhood Weight Alter Health Risks in Adults?

Self-perceived weight as a child may influence risks for all-cause mortality and incident cardiovascular disease in adults who are overweight or obese.

MedScape 14 May at 05.41 AM

Vosoritide Boosts Growth in Several Short Stature Conditions

Already approved for treating achondroplasia, the drug also appears to accelerate growth in children with other genetic growth-limiting conditions.

HealthDay 13 May at 10.34 PM

Physicians With Disabilities May Experience Depersonalization

Physicians with disabilities (PWDs) are significantly more likely to experience depersonalization but not emotional exhaustion when compared with their peers without disabilities, according to a research letter published online May 9 in&nbsp;JAMA Network Open.Lisa M. Meeks, Ph.D., from the University of Michigan Medical School in Ann Arb

MedScape 13 May at 09.17 AM

Food Marketing on Video Games Tied to Teen Eating Behavior

Exposure to branded products on live-streaming video game platforms may drive excess eating and weight gain.

MedScape 13 May at 06.02 AM

CAH Treatment 'Struggle' Points to Unmet Need

Inadequate current treatment of congenital adrenal hyperplasia using glucocorticoids suggested potential benefit of investigational drug.

HealthDay 10 May at 03.57 PM

Cardiovascular, Kidney, and Metabolic Syndrome Highly Prevalent in the U.S.

Cardiovascular, kidney, and metabolic (CKM) syndrome is highly prevalent in the United States, with more than 90 percent of adults meeting the criteria for stage 1 or higher, according to a research letter published online May 8 in the Journal of the American Medical Association.Rahul Aggarwal, M.D., from Harvard Medical School in Boston

MedScape 10 May at 02.43 PM

If at First Tirzepatide Doesn't Succeed, Keep Trying

Treatment guidelines that advise stopping a weight-loss drug if weight loss isn't achieved by 12 weeks don't account for the titration required, investigator says.

HealthDay 10 May at 12.42 PM

Cyberattack Cripples Major U.S. Health Care Network

Ascension, a major U.S. health care system with 140 hospitals in 19 states, announced late Thursday that a cyberattack has caused disruptions at some of its hospitals."Systems that are currently unavailable include our electronic health records system, MyChart (which enables patients to view their medical records and communicate with their provid

MedScape 10 May at 12.04 PM

Teprotumumab Treats Thyroid Eye Disease Across Age

Findings refute those of a prior study suggesting a better response in older vs younger patients.

MedScape 10 May at 07.46 AM

Prevention of Diabetes Complications Lags in Latin America

Data suggest a lack of compliance with assessments to prevent ophthalmologic and neuropathic complications of diabetes in several countries.

MedScape 10 May at 05.03 AM

Arsenic in Community Water Raises Type 2 Diabetes Risk

Even low levels of arsenic in drinking water, below the current regulatory limits, increased the risk for incident T2D in racially and ethnically diverse urban US communities.

MedScape 10 May at 01.54 AM

Kids and Anti-Obesity Meds: Real-World Challenges

The new anti-obesity drugs could be as beneficial for the treatment of adolescents as adults — but obstacles may require creative strategies.

HealthDay 09 May at 09.03 PM

Those With Limited English Proficiency Face Barriers to Telehealth

For individuals with limited English proficiency, there are disparities in telehealth access, as well as worse video visit experiences, according to a research letter published May 9 in&nbsp;JAMA Network Open.Jorge A. Rodriguez, M.D., from Brigham and Women's Hospital in Boston, and colleagues used data from 24,453 adult participants in

HealthDay 09 May at 08.57 PM

Researchers Quantify the Risk for Diabetes After Gestational Diabetes

Gestational diabetes is associated with an increased risk for subsequent diabetes, with higher risk for gestational diabetes in second pregnancy and in both first and second pregnancies, according to a study published online May 9 in JAMA Network Open.Joseph Mussa, from McGill University in Montreal, and colleagues compared the hazards

HealthDay 09 May at 06.04 PM

More Than 200 Insulin Pump Users Injured After App Causes Malfunction

The U.S. Food and Drug Administration has issued a Class 1 recall -- its most urgent kind -- for an IOS app linked to a specific kind of insulin pump used by people with diabetes.The <a href="https://www.fda.gov/medical-devices/medical-device-recalls/tandem-diabetes

HealthDay 09 May at 03.53 PM

Mortality Slightly Increased With Consumption of Ultraprocessed Foods

Mortality is slightly higher in association with a higher intake of ultraprocessed foods, according to a study published online May 8 in The BMJ.Zhe Fang, M.B.B.S., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues conducted a population-based cohort study to examine the association of ultraprocessed food cons

HealthDay 08 May at 10.09 PM

Distal Symmetric Polyneuropathy Often Undiagnosed

Distal symmetric polyneuropathy (DSP) is common and is frequently undiagnosed, according to a study published online May 8 in Neurology.Melissa A. Elafros, M.D., Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined whether data accurately reflect the prevalence, risk factors, and burden of DSP in the population.

MedScape 08 May at 03.19 PM

Tandem Recall Urges Updating App Used With Insulin Pump

The recall warns of a software glitch with the t:connect mobile app that can lead to battery failure of the t:slim X2 insulin pump.

MedScape 08 May at 10.22 AM

Don't Overlook Cardiovascular Risk in Type 1 Diabetes

A new review paper summarized what is and isn't known.

MedScape 08 May at 09.12 AM

Vitamin Shoppe's Telehealth Service to Provide Access to Weight-loss Drugs

Health and wellness products retailer Vitamin Shoppe said on Wednesday that subscribers to its telehealth service would have access to weight-loss medications such as...

MedScape 08 May at 09.00 AM

Free T4 Measure May Not Aid in Thyroid Function Testing

Low free T4 is common, but the incidence of central hypothyroidism is rare.

MedScape 08 May at 06.54 AM

Diabetic Neuropathic Pain: Which Treatments Work?

At a recent conference, experts reviewed the data about pharmaceutical treatments, topical medicines, and neuromodulation for this indication.

HealthDay 07 May at 03.02 PM

Time-Restricted Eating + High-Intensity Training Aids Women With Obesity, Inactivity

Combining time-restricted eating (TRE) with high-intensity functional training (HIFT) may have superior effects on body composition, lipid profile, and glucose regulation among inactive women with obesity compared with diet or exercise interventions alone, according to a study published online May 1 in PLOS ONE.Ranya Ameur, from Universi

MedScape 07 May at 09.35 AM

Continuous Glucose Monitors Gain Favor in Obesity

The off-label use of CGMs for people possibly on the verge of, but not yet diagnosed with, diabetes is seen as a potential tool to help reverse course; over-the-counter version highly anticipated.

MedScape 07 May at 06.11 AM

Why Do Some Obesity Interventions Work Longer Than Others?

The time to weight loss plateau is longer with both GLP-1 receptor agonists and bariatric surgery than with diets alone due to their effect on appetite, not energy expenditure.

HealthDay 06 May at 03.46 PM

Exposure to Food Additive Emulsifiers Linked to Risk for Type 2 Diabetes

Exposure to food additive emulsifiers is associated with an increased risk for type 2 diabetes, according to a study published in the May issue of The Lancet Diabetes &amp; Endocrinology.Clara Salame, Ph.D., from the Université Sorbonne Paris Nord and Université Paris Cité, and colleagues analyzed data from 104,139 adults enrolled in the

MedScape 06 May at 07.52 AM

Do People With Diabetes Need to Fast Longer Before Surgery?

New data find gastric contents after fasting aren't higher than nondiabetics, but an expert endocrinologist disputes that conclusion and GLP-1 agonists further complicate the picture.

MedScape 06 May at 01.39 AM

Intensive Therapy Beneficial in T2D and Early Hypertension

Compared with standard antihypertensive therapy, intensive antihypertensive therapy may significantly benefit women with T2D whose hypertension is diagnosed earlier in life.